Logo image of DTEA

DAVIDSTEA INC (DTEA) Stock Fundamental Analysis

NASDAQ:DTEA - Nasdaq - CA2386611024 - Common Stock - Currency: USD

0.52  -0.01 (-1.89%)

After market: 0.4699 -0.05 (-9.63%)

Fundamental Rating

2

Taking everything into account, DTEA scores 2 out of 10 in our fundamental rating. DTEA was compared to 121 industry peers in the Specialty Retail industry. DTEA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DTEA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DTEA had negative earnings in the past year.
DTEA had a positive operating cash flow in the past year.
DTEA had negative earnings in 4 of the past 5 years.
In multiple years DTEA reported negative operating cash flow during the last 5 years.
DTEA Yearly Net Income VS EBIT VS OCF VS FCFDTEA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M

1.2 Ratios

The profitability ratios for DTEA are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DTEA Yearly ROA, ROE, ROICDTEA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 100 -100

1.3 Margins

With a decent Gross Margin value of 40.93%, DTEA is doing good in the industry, outperforming 64.75% of the companies in the same industry.
In the last couple of years the Gross Margin of DTEA has declined.
DTEA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y-3.74%
DTEA Yearly Profit, Operating, Gross MarginsDTEA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

DTEA does not have a ROIC to compare to the WACC, probably because it is not profitable.
DTEA has more shares outstanding than it did 1 year ago.
The debt/assets ratio for DTEA is higher compared to a year ago.
DTEA Yearly Shares OutstandingDTEA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
DTEA Yearly Total Debt VS Total AssetsDTEA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

DTEA has an Altman-Z score of 0.14. This is a bad value and indicates that DTEA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DTEA (0.14) is worse than 82.73% of its industry peers.
DTEA has a debt to FCF ratio of 2.05. This is a good value and a sign of high solvency as DTEA would need 2.05 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.05, DTEA belongs to the best of the industry, outperforming 84.89% of the companies in the same industry.
DTEA has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
DTEA has a better Debt to Equity ratio (0.22) than 66.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.05
Altman-Z 0.14
ROIC/WACCN/A
WACC10.2%
DTEA Yearly LT Debt VS Equity VS FCFDTEA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.50 indicates that DTEA has no problem at all paying its short term obligations.
DTEA's Current ratio of 2.50 is amongst the best of the industry. DTEA outperforms 87.77% of its industry peers.
DTEA has a Quick Ratio of 1.17. This is a normal value and indicates that DTEA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DTEA (1.17) is better than 75.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 1.17
DTEA Yearly Current Assets VS Current LiabilitesDTEA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DTEA have decreased strongly by -122.35% in the last year.
The Revenue for DTEA has decreased by -12.14% in the past year. This is quite bad
Measured over the past years, DTEA shows a very negative growth in Revenue. The Revenue has been decreasing by -13.59% on average per year.
EPS 1Y (TTM)-122.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-151.1%
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y-21.21%
Revenue growth 5Y-13.59%
Sales Q2Q%-27.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTEA Yearly Revenue VS EstimatesDTEA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
DTEA Yearly EPS VS EstimatesDTEA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 0.1 -0.1 0.2 0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DTEA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DTEA Price Earnings VS Forward Price EarningsDTEA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of DTEA indicates a rather cheap valuation: DTEA is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.55
EV/EBITDA N/A
DTEA Per share dataDTEA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DTEA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DAVIDSTEA INC

NASDAQ:DTEA (4/14/2023, 8:00:00 PM)

After market: 0.4699 -0.05 (-9.63%)

0.52

-0.01 (-1.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)04-27 2023-04-27
Inst Owners0.01%
Inst Owner Change-71.84%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.84M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 3.55
P/OCF 3.47
P/B 0.5
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY28.14%
OCF(TTM)0.15
OCFY28.82%
SpS2.55
BVpS1.05
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.93%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y-3.74%
F-Score2
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.05
Debt/EBITDA N/A
Cap/Depr 3.25%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 1.17
Altman-Z 0.14
F-Score2
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)10.69%
Cap/Depr(5y)52.02%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-151.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y-21.21%
Revenue growth 5Y-13.59%
Sales Q2Q%-27.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-559.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.45%
OCF growth 3YN/A
OCF growth 5YN/A